The internal development leadership team of the Nasdaq-listed biotechnology company, Morphic Therapeutics, sought support in the clinical development planning and indication prioritization for a pre-clinical asset with a novel mechanism…
Read More
Japan-based biotech, a spin-out from Takeda, focusing on rare diseases, looking for support to translate their lead asset to the clinic.
Read More
Boston based biotechnology company operating under a Series A raise focused on oncology and immune mediated conditions.
Read More
A publicly-listed company developing oncology therapeutics looking to exploit the effects of a previously approved compound in combination with other anticancer agents
Read More
US East-coast biopharma startup, a spinout from Major Pharma, repurposing an asset to for a women’s health indication, in need of clinical development expertise as well as support with regulatory…
Read More
A small Swiss-based biotech developing a stem-cell-derived product, requesting strategic and medical leadership and clinical development support.
Read More
Early-stage biopharma company in need of a product development team for their pre-clinical-stage drug-device combination approach for an immune mediated disorder.
Read More
